Antibiotics and outcomes of cancer immunotherapy: An updated meta-analysis and clinical applications
Cancer Cell · 2026-11 · 44 (11) · 2132-2153
DOI: 10.1016/j.ccell.2026.09.012 ↗Kurz gefasst
Metaanalyse in der Zeitschrift Cancer Cell, 2026-11. Verfasst von Serena Porcari und 32 weiteren Autor:innen. Beteiligte Einrichtung: Department of Translational Medicine and Surgery, Università Cattolica del Sacro Cuore Facoltà di Medicina e Chirurgia, Roma, Italy; Department of Me…. Hauptthemen laut MEDLINE: Neoplasms, Anti-Bacterial Agents, Immunotherapy, Immune Checkpoint Inhibitors. Die Arbeit nennt 215 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: Italian Government Ministry of Health, Bristol-Myers Squibb Company, Pfizer Inc.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Translational Medicine and Surgery, Università Cattolica del Sacro Cuore Facoltà di Medicina e Chirurgia, Roma, Italy; Department of Medical and Surgical Sciences, UOC CEMAD Centro Malattie dell'Apparato D…
- Department of Gastroenterology & Hepatology, University of Groningen, University Medical Center Groningen, Groningen, the Netherlands; Department of Diabetes, Endocrinology, Nutritional Medicine and Metabolism, Inselspi…
- Department of Gastroenterology & Hepatology, University of Groningen, University Medical Center Groningen, Groningen, the Netherlands.
- Department of Hematology-Oncology, University of Montreal Hospital Centre, Montreal, QC, Canada; Axe Cancer, Centre de Recherche du Centre Hospitalier de l'Université de Montréal (CRCHUM), Montréal, QC, Canada.
- Université Paris-Saclay, Gustave Roussy, ClinicoBiome, Inserm UMR1367, Microbiota and Mucosal Immunity for Cancer Immunotherapy, 94805 Villejuif, France.
- Department of Translational Medicine and Surgery, Università Cattolica del Sacro Cuore Facoltà di Medicina e Chirurgia, Roma, Italy.
Förderung
- Italian Government Ministry of Health
- Bristol-Myers Squibb Company
- Pfizer Inc
- European Research Council
- Airc Italian Foundation for Cancer Research
- Catholic University of the Sacred Heart
- Horizon Europe
- Seerave Foundation
Zitieren
APA
Porcari, S., Bolte, L. A., Björk, J. R., Elkrief, A., Derosa, L., Ferrari, M., Pezzullo, A. M., Severino, A., Fusco, W., Messaoudene, M., Costa Silva, C. A., Fidelle, M., Routy, B., Mählmann, L., Thomas, A. M., Ciccarese, C., Nero, C., Fagotti, A., Tortora, G., …, & Seerave Global Oncobiome Network (2026). Antibiotics and outcomes of cancer immunotherapy: An updated meta-analysis and clinical applications. Cancer Cell, 44(11), 2132-2153. https://doi.org/10.1016/j.ccell.2026.09.012
Vancouver
Porcari S, Bolte LA, Björk JR, Elkrief A, Derosa L, Ferrari M, et al. Antibiotics and outcomes of cancer immunotherapy: An updated meta-analysis and clinical applications. Cancer Cell. 2026;44(11):2132-2153. doi:10.1016/j.ccell.2026.09.012
BibTeX
@article{Porcari2026,
author = {Porcari, Serena and Bolte, Laura A and Björk, Johannes R and Elkrief, Arielle and Derosa, Lisa and Ferrari, Margherita and Pezzullo, Angelo Maria and Severino, Andrea and Fusco, William and Messaoudene, Meriem and Costa Silva, Carolina Alves and Fidelle, Marine and Routy, Bertrand and Mählmann, Laura and Thomas, Andrew M and Ciccarese, Chiara and Nero, Camilla and Fagotti, Anna and Tortora, Giampaolo and Gasbarrini, Antonio and Iacovelli, Roberto and Bria, Emilio and Futreal, Andy and McQuade, Jennifer and Kroemer, Guido and Hospers, Geke A P and de Haan, Jacco J and Wargo, Jennifer and Segata, Nicola and Weersma, Rinse K and Ianiro, Gianluca and Zitvogel, Laurence and Seerave Global Oncobiome Network, Seerave Global Oncobiome Network},
title = {Antibiotics and outcomes of cancer immunotherapy: An updated meta-analysis and clinical applications},
journal = {Cancer Cell},
year = {2026},
volume = {44},
number = {11},
pages = {2132--2153},
doi = {10.1016/j.ccell.2026.09.012}
}
EUVIMED